Business Wire - September 12, 2003
Why It Matters
UNICEF noted that while Africa accounts for only 12 per cent of the world's population, it claims 43 per cent of the world's child deaths, 50 per cent of maternal deaths in childbirth, 70 per cent of people living with HIV/AIDS, and a staggering 90 percent of all children orphaned by AIDS.
Strategic Links to Africa
Dr. Wambugu, Executive Director of AHBFI is networked with numerous organizations, one being, New Partnerships for Africa Development (NEPAD). Dr. Wambugu, as a passionate believer in service to humankind, also serves on the board of the Bill & Melinda Gates Foundation: Global Health Challenge and the United Nations: Hunger Task Force, providing the collaboration with an incredible strategic link to Africa.
Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals and Chairman and Founder of SIS Foundation stated, "Dr. Wambugu is awesome. Immediately, you sense her passion for Africa, and it becomes contagious."
Humanitarian Purpose
The purpose of the collaboration is to concentrate on alleviating the life-and-death challenges facing children and adults with AIDS in Africa. Samaritan's HIV drug has proved promising, safe and effective through proof of concept Phase II clinical human trials. Samaritan hopes to be able to offer this drug, upon FDA approval, at a very low cost to suffering patients.
SIS Foundation Humanitarian Plan
SISF proposes to work with Kenya, AHBFI Africa, WHO, the UN, IntegriHeatlh, and NBC Africa Ltd. to conduct clinical trials first in Kenya and then Johannesburg, Africa. Should these trials prove successful, SISF will continue to work with its collaborative partners to make the drug available to all sub-Saharan Africans with HIV.
About Samaritan Innovative Science Foundation
The SIS Foundation is an independent charitable foundation established by Samaritan Pharmaceuticals, Inc. The Foundation's primary mission is, to demonstrate a Samaritan love of humankind by relieving human misery and suffering. SISF focuses on improving "quality of life" for the underserved and the underprivileged, with a special emphasis on the children of the world with AIDS. http://www.samaritanpharma.org
About A Harvest Biotech Foundation International
"A Harvest" is a non-profit organization incorporated in California, USA. It is registered in Kenya and South Africa as a non-profit organization (NGO) and has operational offices in the three countries. The Foundation is governed by a Board of Directors with local, African and international experience. http://www.ahbfi.org/biotech/
About Samaritan Pharma: "A Little Bridge Can Go a Long Way"
Samaritan Pharmaceuticals, in collaboration with Georgetown University, drives to bridge the gap by effectively translating research from the bench to the bedside. Samaritan strives to accelerate preclinicals, thru human "proof of concept" trials; lessening the time breakthrough drugs, reach suffering Alzheimer's, Cancer, Cardiovascular, and HIV patients. http://www.samaritanpharma.com
Disclaimer
The company disclaims any information that is created by an outside party and endorses only information that is communicated by its press releases, filings and Web site. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science and technology. However, as with any biopharmaceutical under development, there are significant risks and uncertainties in the process of development and regulatory review. There are no guarantees that products will prove to be commercially successful. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K filed May 15, 2003. The company undertakes no duty to update forward-looking statements.
Contact: Samaritan Innovative Science Foundation, George Weaver 702/735-7001, Fax 702/737-7016, Email Gweaver@samaritanpharma.org. Visit Web site for Samaritan Innovative Science Foundation at www.samaritanpharma.org
CONTACT: Samaritan Innovative Science Foundation
George Weaver, 702-735-7001
Fax: 702-737-7016
Email: GWeaver@samaritanpharma.org
SOURCE: Samaritan Pharmaceuticals Inc.
030912
BW030910
Copyright © 2003 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .